Reversal of experimental diabetes in mice by transplantation of neo-islets generated from human amnion-derived mesenchymal stromal cells using immuno-isolatory macrocapsules

Cytotherapy

Volumn 12, Issue 8, 2010, Pages 982-991

  Kadam, Sachin S ^a   Sudhakar, M ^b   Nair, Prabha D ^b   Bhonde, Ramesh R ^a,c  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

^b SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

^c Stempeutics Research Pvt Ltd   (India)

Author keywords

diabetes reversal; human amniotic membrane; islet neogenesis; mesenchymal stromal cells

Indexed keywords

CELL MARKER; GLUCAGON; GLUCOSE; GROWTH FACTOR; HUMAN INSULIN; NEUROGENIN 3; POLYURETHAN; POVIDONE; SOMATOSTATIN;

AMNION; AMNION CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; CULTURE MEDIUM; ENCAPSULATION; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL;

EID: 77958126915     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2010.509546     Document Type: Article

References (31)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-53.
2. Daneman D. Type 1 diabetes. Lancet. 2006;367:847-58.
3. Shapiro AMJ, Lakey JRT, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immuno-suppressive regimen. New Engl J Med. 2000;343:230-8.
4. Serup P, Madsen OD, Mandrup-Poulsen T. Science, medicine, and the future: islet and stem cell transplantation for treating diabetes. Br Med J. 2001;322:29-32.
5. Ramiya VK, Maraist M, Arfors KE, Schatz DA, Peck AB, Cornelius JG. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nature Med. 2000;6:278-82.
6. Bonner-Weir S, Taneja M, Weir GC, Tatarkiewicz K, Song KH, Sharma A, et al. In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA. 2000;97: 7999-8004.
7. Soria B, Roche E, Berná G, León-Quinto T, Reig JA, Martín F. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes. 2000;49:157-62.
8. Yang L, Li S, Hatch H, Ahrens K, Cornelius JG, Petersen BE, et al. In vitro trans-differentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci USA. 2002;99:8078-83.
9. Koblas T, Zacharovová K, Berková Z, Leontovic I, Dovolilová E, Zá mecník L, et al. In vivo differentiation of human umbilical cord blood-derived cells into insulin-producing cells. Folia Biol. 2009;55:224-32.
10. Denner L, Bodenburg Y, Zhao JG, Howe M, Cappo J, Tilton RG, Saudek F. Directed engineering of umbilical cord blood stem cells to produce C-peptide and insulin. Cell Prolif. 2007; 40:367-80.
11. Sun B, Roh KH, Lee SR, Lee YS, Kang KS. Induction of human umbilical cord blood-derived stem cells with embryonic stem cell phenotypes into insulin producing islet-like structure. Biochem Biophys Res Comm. 2007;354:919-23.
12. Chen LB, Jiang XB, Yang L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol. 2004;10:3016-20.
13. Taneera J, Rosengren A, Renstrom E, Nygren JM, Serup P, Rorsman P, et al. Failure of transplanted bone marrow cells to adopt a pancreatic ß -cell fate. Diabetes. 2006;55: 290-6.
14. In ' t Anker PS, Scherjon SA, Kleijburg-Van Der Keur C, De Groot-Swings GMJS, Claas FHJ, Fibbe WE, et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22:1338-45.
15. Portmann-Lanz CB, Schoeberlein A, Huber A, Sager R, Malek A, Holzgreve W, et al. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol. 2006;194: 664-73.
16. Soncini M, Vertua E, Gibelli L, Zorzi F, Denegri M, Albertini A, et al. Isolation and characterization of mesenchy-mal cells from human fetal membranes. J Tissue Eng Regen Med. 2007;1:296-305.
17. Wolbank S, Peterbauer A, Fahrner M, Hennerbichler S, Van Griensven M, Stadler G, et al. Dose-dependent immu-nomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng. 2007;13:1173-83.
18. Chang CM, Kao CL, Chang YL, Yang MJ, Chen YC, Sung BL, et al. Placenta-derived multipotent stem cells induced to differentiate into insulin-positive cells. Biochem Biophys Res Commun. 2007;357:414-20.
19. Krotzsch-Gomez FE, Furuzawa-Carballeda J, Reyes-Marquez R, Hernandez E, Diaz de Leon L. Cytokine expression is downregulated by collagen- polyvinylpyrrolidone in hyper-trophic scars. J Invest Dermatol. 1998;111:828-34.
20. Nair PD. A process for the preparation of a biocompatible, polymeric composition of an interpenetrating polymeric network. Indian Patent No. 230740. 2009 Feb 27.
21. Toda A, Okabe M, Yoshida T, Nikaido T. The potential of amniotic membrane/amnion-derived cells for regeneration of various tissues. J Pharmacol Sci. 2007;105:215-28.
22. Gershengorn MC, Hardikar AA, Wei C, Ceras-Raaka E, Marcus-Samuels B, Raaka BM. Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science. 2004;306:2261-4.
23. Clark SA, Borland KM, Sherman SD, Rusack TC, Chick WL. Staining and in vitro toxicity of dithizone with canine, porcine, and bovine islets. Cell Transplant. 1994;3:299-306.
24. Horio F, Teradaira S, Imamura T, Anunciado RVP, Kobayashi M, Namikawa T, et al. The HND mouse, a nonobese model of type 2 diabetes mellitus with impaired insulin secretion. Eur J Endocrinol. 2005;153:971-9.
25. Phadnis SM, Joglekar MV, Venkateshan V, Ghaskadbi SM, Hardikar AA, Bhonde RR. Human umbilical cord blood serum promotes growth, proliferation, as well as differentiation of human bone marrow-derived progenitor cells. In vitro Cell Devel Biol Anim. 2006;42:283-6.
26. Shetty P, Bharucha K, Tanavde V. Human umbilical cord blood serum can replace fetal bovine serum in the culture of mesenchymal stem cells. Cell Biol Int. 2007;31:293-8.
27. Keyser KA, Beagles KE, Kiem HP. Comparison of mesenchy-mal stem cells from different tissues to suppress T-cell activation. Cell Transplant. 2007;16:555-62.
28. Hardikar AA, Risbud MV, Bhonde RR. A simple microcap-sule generator design for islet encapsulation. J Biosci. 1999;24: 371-6.
29. Risbud MV, Bhargava S, Bhonde RR. In vivo biocompatibility evaluation of cellulose macrocapsules for islet immunoisola-tion: implications of low molecular weight cut-off. J Biomed Mat Res A. 2003;66:86-92.
30. Soon-Shiong P. Treatment of type I diabetes using encapsulated islets. Adv Drug Deliv Rev. 1999;35:259-70.
31. Schmidt RJ, Chung LY, Andrews AM, Spyratou O, Turner TD. Biocompatibility of wound management products: a study of the effects of various polysaccharides on murine L929 fibroblast proliferation and macrophage respiratory burst. J Pharm Pharmacol. 1993;45:508-13.